21173 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Virus inactivated (killed)
Duck enteritis virus and the uses thereof
#302Duck Enteritis Virus and the uses thereof
#303vaccine
#304Compositions, methods and uses for thermally stable multi-targeted antigens
#305Live attenuated virus vaccines for La Crosse virus and other bunyaviridae
#306Complex containing oligonucleotide having immunopotentiating activity and use thereof
#307Substitutions-modified prefusion RSV F proteins and their use
#308Synergistic co-administration of computationally optimized broadly reactive antigens for human and avian H5N1 influenza
#309Influenza virus vaccines and uses thereof
#310Human rotavirus G9P[6] strain and use as a vaccine
#311NASAL INFLUENZA VACCINE COMPOSITION
#312Composition comprising PIC for treatment of cancer
#313Type II pseudorabies virus attenuated strain, its preparation method and application
#314Infectious disease vaccines
#315Influenza vaccine
#316INACTIVATED VACCINE FOR CHIKUNGUNYA VIRUS
#317Method of producing cells resistant to HIV infection
#318Mesenchymal stem cells as vaccine adjuvants and methods for using the same
#319Immune enhancing recombinant dengue protein
#320Adjuvant compositions
#321ENHANCED IMMUNE RESPONSE IN AQUATIC SPECIES
#322POULTRY VIRUS VACCINES THAT ARE LIQUID STABLE
#323Zika virus purification
#324Reduced foaming vaccine compositions
#325Vaccine compositions
#326Vaccine containing immobilized virus particles
#327Zika virus vaccine
#328Composition comprising iscom particles and live micro-organisms
#329Virus purification
#330Virus purification
#331Zika virus purification
#332Compositions and methods for stabilization of active agents
#333Inactivation of viruses by delipidation
#334Vaccine composition and preparation method and use thereof
#335Method for inactivating viruses using electron beams
#336MODIFIED HUMAN ROTAVIRUSES AND USES THEREFOR
#337CHIKV RNA vaccines
#338METHODS FOR TREATING, PREVENTING AND DIAGNOSING PORCINE EPIDEMIC DIARRHEA VIRUS INFECTION
#339Cross-reactive T-cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats
#340INFLUENZA VIRUS VACCINES AND USES THEREOF
#341Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
#342Broad-spectrum vaccine against avian reovirus
#343Dried influenza vaccine preparation and method for producing dried influenza vaccine preparation
#344Vaccine pharmaceutical composition for oral administration and method for manufacturing vaccine pharmaceutical composition for oral administration
#345Vaccine compositions
#346Prefusion RSV F proteins and their use
#347INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF
#348Human antibodies to Fel d1 and methods of use thereof
#349Porcine pestvirus, vaccines, and assays
#350METHODS AND COMPOSITIONS USEFUL IN GENERATING NON CANONICAL CD8+ T CELL RESPONSES
#351H3 influenza A virus
#352ANTI-TUMORAL COMPOSITION
#353Zika RNA vaccines
#354CDNA clone-launched platform for high-yield production of inactivated zika virus
#355Herpes simplex virus type-1(HSV-1) vaccine strain VC2 generating an anti-EHV-1 immune response
#356Foot-and-mouth disease vaccine
#357Methods of treating and preventing influenza infections
#358Inactivated canine influenza vaccines and methods of making and uses thereof
#359Treatment of pigs with PCV2 antigen
#360Viral vaccines and methods of forming the same
#361INACTIVATED VIRUS COMPOSITIONS AND METHODS OF PREPARING SUCH COMPOSITIONS
#362INACTIVATED VIRUS COMPOSITIONS AND METHODS OF PREPARING SUCH COMPOSITIONS
#363Nanoparticle based vaccine strategy against swine influenza virus
#364Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors
#365Human rotavirus vaccine strains and diagnostics
#366Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#367Porcine epidemic diarrhea virus vaccine
#368ADJUVANTED INFLUENZA VACCINES FOR PEDIATRIC USE
#369Respiratory syncytial virus with a genomic deficiency complemented in trans
#370THERAPEUTIC VACCINE FOR TREATING OR PREVENTING MERKEL CELL POLYOMA VIRUS-ASSOCIATED TUMORS
#371Method for porcine circovirus production and PCV2 vaccines
#372METHODS FOR PRODUCING VIRUS FOR VACCINE PRODUCTION
#373Hand, foot, and mouth vaccines and methods of manufacture and use thereof
#374Duck enteritis virus and the uses thereof
#375Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#376Antigenically matched influenza vaccines
#377VACCINE CONTAINING VIRUS INACTIVATED BY GREEN TEA EXTRACT, AND PREPARATION METHOD THEREFOR
#378Pestivirus vaccines for congenital tremors
#379Vaccine adjuvant composition comprising inulin particles
#380Materials and methods for respiratory disease control in canines
#381Multivalent enterovirus vaccine compositions and uses related thereto
#382Immortalized porcine alveolar macrophage
#383Stable, Spray Dryed, Immunogenic, Viral Compositions
#384Vaccine against porcine parvovirus and porcine reproductive and respiratory syndrome virus and methods of production thereof
#385Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#386Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof
#387Hand, foot, and mouth vaccines and methods of manufacture and use thereof
#388Immune complex
#389POULTRY VIRUS VACCINES THAT ARE LIQUID STABLE
#390Live attenuated virus vaccines for la crosse virus and other bunyaviridae
#391Lymph node-targeting nanoparticles
#392Thermal inactivation of rotavirus
#393compositions and methods thereof
#394H3 influenza A virus
#395Combination purified inactivated vaccine for flaviviruses
#396Liposomal adjuvant compositions
#397Stable, Spray Dryed, Immunogenic, Viral Compositions
#398Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
#399Circovirus sequences associated with piglet weight loss disease (PWD)
#400Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers
#401Method for preparing a vaccine antigen, resulting vaccine antigen and uses
#402Vaccine against infectious bronchitis virus
#403Nanoemulsion respiratory syncytial virus (RSV) subunit vaccine
#404Dengue virus vaccine compositions and methods of use thereof
#405METHOD FOR AMELIORATING AND ABATING SYMPTOMS RESULTING FROM RHEUMATOID ARTHRITIS, FIBROMYALGIA, AND CHRONIC PAIN OF UNKNOWN ORIGIN
#406Methods for enterovirus inactivation, adjuvant adsorption and dose reduced vaccine compositions obtained thereof
#407A Rabies Composition Comprising Pika Adjuvant
#408Cross-protective pathogen protection, methods and compositions thereof
#409Influenza virus reassortment
#410Adjuvant compositions
#411VACCINE COMPOSITIONS AND METHODS OF USE TO TREAT NEONATAL SUBJECTS
#412Vaccine for use in protecting a pig against porcine epidemic diarrhea virus
#413Compositions and methods for increasing immunogenicity of glycoprotein vaccines
#414Vaccine compositions against dengue virus diseases
#415Methods for preparing aluminum precipitate compounds for use in therapeutics and vaccines
#416Vaccine for Use in Protecting Offspring of a Sow Against Porcine Endemic Diarrhea Virus
#417Multi-CBV vaccine for preventing or treating type I diabetes
#418Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
#419COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS
#420Inactivated equine influenza virus vaccines
#421A BLUETONGUE VACCINE AND METHODS OF MANUFACTURE THEREOF
#422Method of quickly producing antibodies against avian influenza and maintain antibody titer of duck
#423SMC combination therapy for the treatment of cancer
#424Vaccine in the form of a recombinant sero type 9 avian adenovirus vector
#425Mixture of non-digestible oligosaccharides for stimulating the immune system
#426Vaccine for PCV2 and mycoplasma
#427PCV/mycoplasma hyopneumoniae/lawsonia intracellularis combination vaccine
#428Human antibodies to Fel d1 and methods of use thereof
#429Mycoplasma hyopneumoniae vaccine
#430Vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus
#431Methods and compositions for the prevention and treatment of influenza
#432ANTIBODY GUIDED VACCINES AND METHODS OF USE FOR GENERATION OF RAPID MATURE IMMUNE RESPONSES
#433Process for producing influenza vaccine
#434Composite antigenic sequences and vaccines
#435Human rotavirus vaccine strains and diagnostics
#436Live attenuated chimeric porcine circovirus vaccine
#437Hybrid core feline vaccines
#438Microneedle-based transdermal delivery system and method of making same
#439Mucosal adjuvants and delivery systems
#440Rhinal spray nozzle used for medical syringe
#441Rhinovaccination system of influenza vaccine
#442Vaccine preparation using ultraviolet radiation
#443LOW-ADDITIVE INFLUENZA VACCINES
#444Chimeric West Nile/Dengue viruses and methods of use
#445H3 influenza A virus
#446Influenza virus reassortment
#447Prevention and treatment of sub-clinical PCVD
#448Cold-adapted-viral-attenuation (CAVA) and novel attenuated poliovirus strains
#449Combinatorial platform for the display of surface adjuvants and antigens
#450Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#451Viral inhibitory nucleotide sequences and vaccines
#452Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins
#453COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS
#454vaccines for congenital tremors
#455Porcine parvovirus
#456Adenoviral vector-based vaccine against enterovirus infection
#457BIOMARKERS FOR PROSTATE CANCER AND METHODS FOR THEIR DETECTION
#458West Nile Virus vaccine
#459Treatment of pigs with PCV2 antigen
#460Immune enhancing recombinant dengue protein
#461Heat Inactivated Poxvirus Improves Vaccination Results
#462Vaccine compositions
#463Cytomegalovirus vaccines and methods of production
#464Vaccine compositions
#465Inactivated whole virion vaccine-containing microneedle array preparation and method for administering the same
#466Monovalent H5 vaccine
#467Human antibodies to fel D1 and methods of use thereof
#468Method of producing an inactivated lentivirus, especially HIV, vaccine, kit and method of use
#469Immunogenic compositions and methods
#470Live attenuated virus vaccines for la crosse virus and other bunyaviridae
#471Influenza virus vaccines and uses thereof
#472Poultry virus vaccines that are liquid stable
#473Method for porcine circovirus production and PCV2 vaccines
#474Cell strain having increased virus production ability and production method therefor
#475Adjuvant for mucosal vaccine
#476Aluminum compounds for use in therapeutics and vaccines
#477Gene-deleted variant strain of porcine pseudorabies virus, vaccine composition, method of making the same and use thereof
#478Immortalized porcine alveolar macrophage
#479PISCINE REOVIRUS IMMUNOGENIC COMPOSITIONS
#480Gene-deleted variant strain of porcine pseudorabies virus, vaccine composition, method of making the same and use thereof
#481USE OF RAPAMYCIN AS VACCINE ADJUVANT AND PREPARATION METHOD THEREFOR
#482NOVEL PNEUMOVIRUS COMPOSITIONS AND METHODS FOR USING THE SAME
#483Tissue targeted antigenic activation of the immune response to treat cancers
#484Marker system, in particular for baculovirus-expressed subunit antigens
#485Reduced foaming vaccine compositions
#486Methods And Compositions For Treatment Of S. Equi Infection
#487Influenza vaccine
#488Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof
#489Nasal mucosal vaccine composition
#490Porcine pseudorabies virus (PRV)-YF strain and its application
#491Use of EGFR pathway inhibitors to increase immune responses to antigens
#492Dry formulations of vaccines that are room temperature stable
#493Compositions containing amino acids, phosphate and manganese and their uses
#494HIV-1 vaccine
#495PCV2B divergent vaccine composition and methods of use
#496Complex containing oligonucleotide having immunopotentiating activity and use thereof
#497Methods of immunization with varicella zoster virus antigen
#498Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#499Intranasal vaccination dosage regimen
#500Methods for the prevention of aggregation of viral components
#501Vaccines for diseases caused by viruses of the family of reoviridae
#502Preparation of influenza virus vaccine antigens
#503Method for inactivating viruses using electron beams
#504Methods for preparing inactivated rotavirus
#505Method for preparing virosomes
#506Hand, foot, and mouth vaccines and methods of manufacture and use thereof
#507Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#508Vaccine stabilizer
#509Attenuated swine influenza vaccines and methods of making and use thereof
#510INACTIVATED DENGUE VIRUS VACCINE WITH ALUMINIUM-FREE ADJUVANT
#511Compositions comprising iscom particles and live micro-organisms
#512Aluminum compounds for use in therapeutics and vaccines
#513Porcine pseudorabies virus, vaccine composition and preparation method and use thereof
#514Neutralizing molecules to influenza viruses
#515Interactions of betanodaviruses in infection
#516Vaccine for PCV2 and mycoplasma
#517Nanoemulsion influenza vaccine
#518Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
#519H3 influenza a virus
#520Prefusion RSV F proteins and their use
#521Alkylated influenza vaccines
#522Formulations
#523Swine influenza viruses and constructs and uses thereof
#524Inactivated Vaccine for Porcine Epidemic Diarrhea Virus (PEDV)
#525Nanoparticle-based compositions
#526Immunogenic compositions comprising silicified virus and methods of use
#527Vaccine comprising an oil in water emulsion
#528Prevention and treatment of sub-clinical PCVD
#529Tissue targeted antigenic activation of the immune response to treat cancers
#530Modified human rotaviruses and uses therefor
#531Influenza virus vaccines and uses thereof
#532Vaccine prepared utilizing human parainfluenza virus type 2 vector
#533Respiratory syncytial virus with a genomic deficiency complemented in trans
#534Influenza virus reassortment
#535Influenza viruses with mutant PB2 segment as live attenuated vaccines
#536Vaccine composition for naive subjects
#537VACCINE COMPOSITION FOR USE IN IMMUNO-COMPROMISED POPULATIONS
#538Human antibodies to fel d1 and methods of use thereof
#539Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof
#540PSORALEN-INACTIVATED DENGUE VIRUS VACCINE AND METHOD OF PREPARATION
#541MARKER VACCINE
#542PCV/mycoplasma hyopneumoniae/PRRS combination vaccine
#543vaccine
#544Porcine epidemic diarrhea virus vaccine
#545Influenza vaccines
#546PCV/combination vaccine
#547Production of viral vaccines in suspension on avian embryonic derived stem cell lines
#548VACCINE
#549Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#550HEPATITIS C VIRUS PARTICLES FORMATION PROMOTER, AND METHOD OF PRODUCING HEPATITIS C VIRUS PARTICLES
#551Liquid stable virus vaccines
#552Porcine parvovirus 5A, methods of use and vaccine
#553NOVEL ATTENUATED DENGUE VIRUS STRAINS FOR VACCINE APPLICATION
#554SPIROCYCLIC ISOXAZOLINE DERIVATIVES FOR TREATMENT OF SEA LICE
#555Reverse genetics of negative-strand RNA viruses in yeast
#556INACTIVATED VARICELLA ZOSTER VIRUS VACCINES, METHODS OF PRODUCTION, AND USES THEREOF
#557Vaccine formulations comprising saponin-containing adjuvants
#558Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#559Immunogenic compositions and methods of use thereof
#560Circovirus sequences associated with piglet weight loss disease (PWD)
#561Circovirus sequences associated with piglet weight loss disease (PWD)
#562Recombinant influenza vectors with tandem transcription units
#563PROTECTION AGAINST DENGUE VIRUS AND PREVENTION OF SEVERE DENGUE DISEASE
#564COMPOSITIONS FOR INACTIVATING PATHOGENIC MICROORGANISMS, METHODS OF MAKING THE COMPOSITIONS, AND METHODS OF USE THEREOF
#565Human rotavirus vaccine strains and diagnostics
#566compositions and methods thereof
#567DSRNAS AS INFLUENZA VIRUS VACCINE ADJUVANTS OR IMMUNO-STIMULANTS
#568Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein
#569Materials and methods for respiratory disease control in canines
#570Equine encephalitis virus vaccines and methods of using thereof
#571Nanocarriers with multi-photon response elements
#572Polyanionic polymer adjuvants for Haemophilus influenzae B saccharide vaccines
#573Immunogenic compositions and methods
#574Alphavirus vectors for respiratory pathogen vaccines
#575Method of treating food allergies by administering a nanoparticle comprising heparin and chitosan encapsulating IL-12
#576Treatment of pigs with PCV2 antigen
#577Adjuvant-sparing multi-dose influenza vaccination regimen
#578Method for formulating a vaccine containing at least two antigens capable of adsorbing onto aluminium oxyhydroxide
#579Attenuated recombinant vesicular stomatitis viruses comprising modified mutant matrix proteins
#580Synthetic capsid proteins and uses thereof
#581Method to enhance an immune response of nucleic acid vaccination
#582West Nile Virus vaccine
#583Influenza virus vaccines and uses thereof
#584Norovirus immunogens and related materials and methods
#585High yield yellow fever virus strain with increased propagation in cells
#586Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof
#587Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof
#588Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance
#589Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
#590Inactivating pathogens with oxidizing agents for vaccine production
#591Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof
#592Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
#593Live attenuated chimeric porcine circovirus vaccine
#594Conditional replicating cytomegalovirus as a vaccine for CMV
#595Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
#596Multivalent vaccines for rabies virus and filoviruses
#597Recombinant vaccine against PRRS in a viral vector
#598Herpes virus vaccine and methods of use
#599Emulsion containing a non-live medicinal substance
#600Cellular permissivity factor for viruses and uses thereof